1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-amine
97%
- Product Code: 114497
CAS:
2044703-06-0
| Molecular Weight: | 285.27 g./mol | Molecular Formula: | C₁₃H₁₄F₃N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30543733 | |
| Melting Point: | Boiling Point: | 424.3±45.0°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, protected from light, stored in an inert gas |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting specific enzymes or receptors. Its structure, featuring a trifluoromethyl group and an indazole core, makes it valuable for developing compounds with potential therapeutic applications, such as anti-inflammatory, anticancer, or antimicrobial agents. Researchers often explore its derivatives to optimize drug efficacy, selectivity, and pharmacokinetic properties. Additionally, it may be used in the study of structure-activity relationships (SAR) to design novel drugs with improved biological activity and reduced side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿12,051.00 |
+
-
|
| 0.250 | 10-20 days | ฿24,111.00 |
+
-
|
1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-amine
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting specific enzymes or receptors. Its structure, featuring a trifluoromethyl group and an indazole core, makes it valuable for developing compounds with potential therapeutic applications, such as anti-inflammatory, anticancer, or antimicrobial agents. Researchers often explore its derivatives to optimize drug efficacy, selectivity, and pharmacokinetic properties. Additionally, it may be used in the study of structure-activity relationships (SAR) to design novel drugs with improved biological activity and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :